Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours

TA86 Gastrointestinal stromal tumours - imatinib: review decision - October 2013 information

TA86 Gastrointestinal stromal tumours - imatinib: Appendix A - decision paper presented to the Institute's Guidance Executive (PDF 109 KB)

TA86 Gastrointestinal stromal tumours - imatinib: review proposal information

TA86 Imatinib for gastrointestinal stromal tumours: Appendix A - provisional matrix of stakeholders (PDF 102 KB)

TA86 Imatinib for gastrointestinal stromal tumours: Appendix B - proposal paper presented to the Institute's Guidance Executive (PDF 467 KB)

Review decision, February 2008 information

Review decision, February 2007 information

Review proposal, October 2007 information

Appendix A - matrix of consultees and commentators (PDF 49 KB)

TA86 Gastrointestinal stromal tumours - imatinib: review proposal information

TA86 Gastro-intestinal stromal tumours (GIST) - imatinib: distribution list (PDF 20 KB)

Assessment report (PDF 929 KB)

Final Appraisal Determination: Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours information

Final Appraisal Determination: Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (PDF 171 KB)

Appraisal Consultation Document: Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours information

Gastrointestinal stromal tumours - imatinib: assessment report (PDF 929 KB)

Agenda and attendee list for the Appraisal Committee Meeting held on Thursday 22nd April (PDF 107 KB)

Protocol: Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours (PDF 160 KB)

Scope: Imatinib for gastrointestinal stromal tumours (PDF 67 KB)

2003/009 NICE asked to develop guidance on treating eczema, support programmes for parents dealing with conduct disorder in children, use of statins for heart disease, and when hysterectomy is appropriate information

2003/009 NICE asked to develop guidance on treating eczema, support programmes for parents dealing with conduct disorder in children, use of statins for heart disease, and when hysterectomy is appropriate (PDF 101 KB)